Small Molecules

22 Aug 2007 BioMarin licenses technology from leading cystic fibrosis research laboratory at the University of California, San Francisco
22 Aug 2007 Sirtris Pharmaceuticals initiates Phase 2a clinical trial in patients with Type 2 diabetes
22 Aug 2007 Abraxis BioScience and The Scripps Research Institute Enter Exclusive Licensing Agreement for the Worldwide Development and Commercialization of a Novel Epothilone Therapeutic for the Treatment of Cancer
22 Aug 2007 Genta Initiates Phase 3 AGENDA Trial of Genasense® for Patients with Advanced Melanoma
22 Aug 2007 Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
22 Aug 2007 Daiichi Sankyo and Forest Laboratories sign Letter of Intent for co-promotion of AZOR(TM)
22 Aug 2007 Lexicon presents class of compounds modulating TPH1, the target for its LX1031 investigational drug for irritable bowel syndrome
22 Aug 2007 New data suggest Cymbalta(R) reduced pain in fibromyalgia patients with and without depression
21 Aug 2007 Elixir Pharmaceuticals initiates final Phase III clinical study prior to NDA
21 Aug 2007 Can-Fite Successfully Completes Preclinical Trials With Its Second Drug Candidate CF102
21 Aug 2007 Metabasis Therapeutics Presents Preclinical Results Demonstrating Potential Advantages of MB07811 as a Treatment for Hyperlipidemia
21 Aug 2007 FDA Grants Tikvah Therapeutics, Inc. Orphan Drug Status for Sodium Phenylbutyrate for the Treatment of Spinal Muscular Atrophy
21 Aug 2007 Nexavar Granted FDA Priority Review for Treatment of Liver Cancer
21 Aug 2007 Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve On Chemotherapy
21 Aug 2007 Pharmion and MethylGene announce collaboration to develop sirtuin inhibitors as anti-cancer agents
19 Aug 2007 Reclast(R) receives US regulatory approval as first and only once-yearly treatment for women with postmenopausal osteoporosis
18 Aug 2007 UCB announces submission of Lacosamide marketing application for diabetic neuropathic pain
18 Aug 2007 Anesiva receives FDA approval for Zingo(TM), a new, innovative product to reduce pain associated with needle insertion procedures in children
18 Aug 2007 Indevus receives approvable letter from FDA for VALSTAR(R) for bladder cancer therapy
18 Aug 2007 MediciNova reports Phase Ib clinical study results for MN-221, a novel treatment for preterm labor
17 Aug 2007 Myriad Genetics initiates Phase 2 clinical trial of Azixa in lung cancer
17 Aug 2007 ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
17 Aug 2007 Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
17 Aug 2007 European EMEA acceptance of Marketing Authorization Application filing for SNT-MC17 in Friedreich's Ataxia by Santhera
17 Aug 2007 Pro-Pharmaceuticals Announces "Compassionate Use" IND for DAVANAT(R) to Treat Biliary Cancer Patient

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up